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Abstract To pro¢le gene expression patterns involved in the
direct myocardial e¡ect of cholesterol-enriched diet-induced hy-
perlipidemia, we monitored global gene expression changes by
DNA microarray analysis of 3200 genes in rat hearts. Twenty-
six genes exhibited signi¢cant up-regulation and 25 showed
down-regulation in hearts of rats fed a 2% cholesterol-enriched
diet for 8 weeks as compared to age-matched controls. The
expression changes of 12 selected genes were also assessed by
real-time quantitative polymerase chain reaction. Genes with
altered expression in the heart due to hyperlipidemia included
procollagen type III, co¢lin/destrin, tensin, transcription repres-
sor p66, synaptic vesicle protein 2B, Hsp86, chaperonin subunit
5O, metallothionein, glutathione S-transferase, protein kinase
C inhibitor, ATP synthase subunit c, creatine kinase, chloride
intracellular channel 4, NADH oxidoreductase and dehydroge-
nase, ¢bronectin receptor L chain, CD81 antigen, farnesyltrans-
ferase, calreticulin, disintegrin, p120 catenin, Smad7, etc.
Although some of these genes have been suspected to be related
to cardiovascular diseases, none of the genes has been previously
shown to be involved in the mechanism of the cardiac e¡ect of
hyperlipidemia.
4 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
A high-cholesterol diet is regarded as an important factor in
the development of cardiac diseases, since it leads to develop-
ment of hyperlipidemia, atherosclerosis, and ischemic heart
disease. The heart of the hyperlipidemic/atherosclerotic pa-
tient adapts poorly to oxidative or other kinds of stress, sug-
gesting that the endogenous adaptive mechanisms against myo-
cardial stress are impaired (see [1] for review). The focus of
research so far has been mainly the coronary e¡ects of cho-
lesterol, i.e. coronary sclerosis, and the possible direct e¡ect of
hypercholesterolemia on the heart was neglected. Very few
studies looked at the cellular e¡ects of cholesterol-enriched
diet on the myocardium. However, intracellular lipid accumu-
lation in cardiomyocytes and several alterations in the struc-
tural and functional properties of the myocardium have been
observed [2,3]. We and others have previously shown that
hyperlipidemia induced by a cholesterol-enriched diet attenu-
ates the cardioprotective e¡ect of ischemic preconditioning via
a mechanism independent of atherosclerosis and other vascu-
lar e¡ects of hyperlipidemia [4,5] (see [6,7] for reviews). Fur-
thermore, we have recently shown that hyperlipidemia leads
to a moderate contractile dysfunction of the heart character-
ized by an elevation of left ventricular end-diastolic pressure
[8]. These results show that hyperlipidemia acts directly on the
myocardium.
The underlying molecular mechanisms of the direct e¡ects
of cholesterol diet-induced hyperlipidemia on the myocardium
have been addressed by a few studies, but the exact biochem-
ical mechanisms are still a question of debate. A variety of
mechanisms, i.e. inhibition of the mevalonate pathway [9],
decrease in NO bioavailability and cGMP metabolism [5,10],
increase in free radical and peroxynitrite formation [8], inhi-
bition of heat shock response [11], and expression of oxidized
low-density lipoprotein receptors which induces apoptosis
[12,13], have been shown to play a role in the cardiac e¡ects
of hyperlipidemia. However, the traditional biochemical and
pharmacological approaches have been insu⁄cient so far to
explore the key cellular events in the heart in hyperlipidemia.
Recent studies have attempted to identify gene activity
changes in atherosclerotic plaques in human and animal blood
vessel samples [14,15]. However, the gene expression pattern
of the heart in response to hyperlipidemia induced by chronic
cholesterol-enriched diet is not known.
Therefore, to pro¢le the gene expression pattern of the
heart associated with hyperlipidemia, we have used cDNA
microarrays with 3200 genes to monitor transcript levels in
rat hearts, in the hope of identifying new cellular pathways
involved in the direct cardiac e¡ects of hyperlipidemia induced
by dietary cholesterol.
2. Materials and methods
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH publication No. 85-23, revised 1996) and was approved
by local ethics committees.
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2.1. Induction of hyperlipidemia
Male Wistar rats (18 weeks old), housed in a room maintained at a
12-h light^dark cycle and a constant temperature of 22Q 2‡C, were fed
laboratory chow enriched with 2% cholesterol or standard chow for
8 weeks as described [5,8,11]. Hearts of rats were chosen for the study,
since this species shows a moderate increase in serum cholesterol level
due to a high-cholesterol diet, and no substantial atherosclerosis de-
velops. However, the increased concentration of tissue cholesterol
leads to strong metabolic e¡ects [16,17]. At the end of the 8-week
diet period, body weights of the animals were 350^400 g, and there
was no signi¢cant di¡erence between groups. Plasma cholesterol and
triglyceride levels increased by approximately 20% and 300%, respec-
tively, which was consistent with our previous ¢ndings [5,8,11]. At the
end of the diet period, hearts were isolated for measurement of car-
diac function and biochemical parameters.
2.2. Perfusion protocol of isolated rat hearts
Animals were anesthetized with diethylether and given 500 U/kg
heparin. Hearts from normal and hyperlipidemic rats (n=8 in each
group) were then isolated and perfused in Langendor¡ mode with
oxygenated, normothermic Krebs^Henseleit bu¡er for 5 min. Subse-
quently, the perfusion was switched to a working mode [18,19] to
measure cardiac mechanical functional and hemodynamic parameters
including heart rate, coronary £ow, aortic £ow, left ventricular devel-
oped pressure and its ¢rst derivatives (+dP/dtmax, 3dP/dtmax), and left
ventricular end-diastolic pressure as described [20]. Lactate dehydro-
genase release was measured from coronary e¥uent collected for 5 min
at the beginning of the perfusion [18]. At the end of the perfusion
protocols, the ventricles of hearts from both groups were cut o¡,
immediately frozen, and powdered with a pestle and mortar in liquid
nitrogen for RNA preparation.
2.3. RNA preparation
Total RNA was puri¢ed from each group (25^25 mg tissue from
each heart) with NucleoSpin RNA puri¢cation kit (Macherey-Nagel,
Du«ren, Germany) according to the manufacturer’s instructions as
described [21]. The quantity and quality of RNA from each sample
was assessed by gel electrophoresis as well as spectrophotometry
(NanoDrop spectrophotometer, NanoDrop, USA). Two RNA pools
were prepared from each group (n=4, randomly selected from each
group) and used in replica experiments. Total RNA was used for
microarray analysis as well as for reverse transcription quantitative
polymerase chain reaction (QRT-PCR).
2.4. Microarrays and probes
Construction and use of microarrays were performed as described
[22,23]. Brie£y, 3200 ampli¢ed cDNA inserts from di¡erent mouse
cDNA libraries were ampli¢ed with vector-speci¢c primers, analyzed
with agarose gel electrophoresis, and puri¢ed with Millipore PCR
puri¢cation plates. Puri¢ed PCR products were reconstituted in 50%
dimethylsulfoxide/water and arrayed in duplicate on FMB cDNA
slides (Full Moon Biosystems, Sunnyvale, CA, USA) using a Micro-
Grid Total Array System spotter (BioRobotics, Cambridge, UK) with
16 pins in a 4U4 grid format. After printing, DNA was UV cross-
linked to the slides with 700 mJ energy (Stratalinker, Stratagene).
Microarray probes were generated by a modi¢ed version of a linear
ampli¢cation technique described before [22,24]. Brie£y, 2 Wg total
RNA from each pooled sample was ampli¢ed. Three Wg of ampli¢ed
RNA was labeled with both Cy5 and Cy3 £uorescent dyes (dye-swap
experiments) during RT with RNase H (3) point mutant M-MLV
reverse transcriptase (Fermentas, Vilnius, Lithuania) and random
nonamers. After RT, RNA was alkali hydrolyzed and labeled
cDNA was puri¢ed with NucleoSpin1 PCR puri¢cation kit (Macher-
ey-Nagel) according to the manufacturer’s instructions. Probes gener-
ated from the control and treated samples were mixed, reconstituted
in 16 Wl hybridization bu¡er (50% formamide, 5USSC, 0.1% SDS,
100 Wg/ml salmon sperm DNA) and applied onto the array after de-
naturation by heating for 1 min at 90‡C. Prior to hybridization, the
slides were blocked in 1USSC, 0.2% SDS, 1% bovine serum albumin
for 30 min at 45‡C, rinsed in water and dried. The slide was covered
by a 22 mmU22 mm coverslip, and sealed with DPX Mountant
(Fluka, Buchs, Switzerland) in order to prevent evaporation. Slides
were incubated at 42‡C for 20 h in a humid hybridization chamber.
After hybridization the mountant was removed and the arrays were
washed by submersion and agitation for 10 min in 1USSC with 0.1%
SDS, for 10 min in 0.1USSC with 0.1% SDS and for 10 min in
0.1USSC at room temperature, then rinsed brie£y in water and dried.
2.5. Scanning and data analysis
Each array was scanned under a green laser (543 nm for Cy3 label-
ing) or a red laser (633 nm for Cy5 labeling) using a ScanArray Lite
(GSI Lumonics, Billerica, MA, USA) scanning confocal £uorescent
scanner with 10 Wm resolution (laser power: 85% for Cy5 and 90% for
Cy3, gain: 75% for Cy5 and 70% for Cy3) [21]. Scanned output ¢les
were analyzed using the GenePix Pro 3.0 software (Axon Instruments,
Foster City, CA, USA). Each spot was de¢ned by automatic position-
ing of a grid of circles over the image. The average and median pixel
intensity ratios calculated from both channels and the local back-
ground of each spot were determined. An average expression ratio
(MeaR, denotes the average of local background corrected pixel in-
tensity ratios) was determined for each spot. Normalization was per-
formed by the global Lowess method [25]. Those data were £agged
and excluded where the replicate spots from a di¡erent site of the
same array or results from the replicate experiments were signi¢cantly
di¡erent. Data analysis was done by the signi¢cance analysis of micro-
arrays method [26] and visualization of scatter images was performed
with the Microsoft EXCEL software. The cholesterol-regulated genes
were determined by calculating the average fold change between heart
samples from untreated and cholesterol-fed animals. From two bio-
logical replicates and two hybridizations altogether four data points
were gathered from each gene. Genes for which the average change
(increase or decrease) of the four data points was at least 1.9-fold were
considered genes regulated by cholesterol diet.
2.6. Real-time QRT-PCR
Con¢rmatory real-time QRT-PCR was performed on a RotorGene
2000 instrument (Corbett Research, Sydney, Australia) with gene-spe-
ci¢c primers and SYBR Green protocol to con¢rm the gene expres-
sion changes observed by DNA microarrays as described [21]. In
brief, 10 Wg of total RNA from each pool was reverse transcribed
in the presence of oligo(dT) primer in a total volume of 20 Wl. After
dilution of the mix with 80 Wl of water, 2 Wl of this mix was used as
template in the QRT-PCR. Reactions were performed in a total vol-
ume of 20 Wl (8 pmol/each forward and reverse primer, 1UBio-Rad
Table 1
Primers used in real-time PCR analysis
Gene product Forward primer Reverse primer
L-Actin GGAAATCGTGCGTGACATTAAA TGCGGCAGTGGCCATC
Chaperonin subunit 5O TACAGCTCTGCAGATGAAGGATGCTT TGACATCCGTAAGCCTGGAGAATCTG
Procollagen, type III, K1 TGGAAGTCAAGGAGAAAGTGGTC AAACCCATGACACCAGGCTG
Synaptic vesicle protein 2B CCACCAACCAGAGGGCC GATGGCACCAAGTTTGCACA
Tensin CGGGTCAAGCTCCGCA TTTCGTGGCCAAGAAGCC
Heat shock protein, Hsp86 GTTGTGTCAAACCGATTGGTGACATCC TGTAGATCCTGTTAGCATGGGTCTGG
Protein kinase C inhibitor S TCATTCACCACCATCCGGT GGCAAGAAATGTGCTGCAGA
Glycogen synthase kinase 3 GCTCCCCAACGACCGC TGGATGGACAGTTCACCAGGA
Metallothionein II TCGCCATGGACCCCAACTGCTCCTGTG GAAGCCTCTTTGCAGATGCAGCCCTG
ATP synthase subunit c TCAAGCAGCAGCTCTTCTCCT GCCCCATGGCCTCAGAC
Chloride intracellular channel 4 GGCCATCTTAAACTCCCGTG CCCAGTCTGATGCACATGGA
ND5 respiratory NADH dehydrogenase ATCGAAGCCATCAACACGTG GCAGTTATGGATGTGGCGATT
CD81 antigen CACCGCCGTGCTGAGG TCCTTCAGAAGCTGAGTGAATGAG
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SYBR Green bu¡er, Bio-Rad, Hungary) with the following protocol:
10 min denaturation at 95‡C, and 45 cycles of 25 s denaturation at
95‡C, 25 s annealing at 59‡C, and 25 s extension at 72‡C. Fluorescent
signals were gathered after each extension step at 72‡C. Curves were
analyzed by the RotorGene software using dynamic tube and slope
correction methods ignoring data from cycles close to baseline. Rela-
tive expression ratios were normalized to L-actin and calculated with
the Pfa¥ method [27]. The PCR primers used in this study are listed
in Table 1. Primers were designed using the ArrayExpress software
(Applied Biosystems). All the PCRs were performed four times in
separate runs.
3. Results and discussion
Relative gene expression changes in rat hearts in response
to cholesterol diet-induced hyperlipidemia were compared to
the expression pro¢les of rats on a normal diet. Changes of
3200 genes were followed by mouse-speci¢c cDNA microar-
rays. Among the 3200 genes examined in the present study an
average of 1324 showed signi¢cant intensity (see Section 2 for
statistical calculations) and 4.0% (51 genes) showed altered
expression: 26 genes exhibited signi¢cant up-regulation (Table
2A) and 25 were down-regulated (Table 2B) after 8 weeks of
high-cholesterol diet. Out of the 51 genes, 43 genes of known
function and eight expressed sequence tags (ESTs) or hypo-
thetical protein genes with unknown function were detected.
The gene expression changes ranged from 34.4-fold to +5.5-
fold (Table 2).
Table 2
Genes with altered expression due to high-cholesterol diet-induced hyperlipidemia in rat hearts
Function Gene product Accession number Microarray (average fold) S.D.
A: Up-regulated genes
Structural proteins Co¢lin/destrin (actin depolymerizing factor) W17549 3.15 0.21
Calsarcin-1, myozenin-like 2 XM_215692 2.35 0.52
Procollagen, type III, K1 W89883 2.14 0.50
Regulatory proteins Protein phosphatase 1, regulatory subunit 9A AA087542 4.80 1.52
Transcription repressor p66 XM_227388 3.38 0.80
Similar to developmentally regulated protein AA259357 3.52 0.39
Pleiotropic regulator 1 AA286018 2.77 0.20
Glycogen synthase kinase 3 NM_032080 1.95 0.04
Protein kinase C inhibitor S NM_022192 1.90 0.03
Adhesion molecules, membrane proteins p120 catenin isoform 4B AW545658 5.48 1.84
SH3-containing protein SH3P4 W34672 5.11 0.74
Clara cell phospholipid binding protein W36838 4.51 0.71
NIPSNAP2 protein W15931 3.00 0.34
Tensin U26310 1.97 0.19
Stress proteins Glutathione S-transferase AA231621 3.26 0.20
Metallothionein II H32024 1.97 0.06
Heat shock protein, Hsp86 AW536140 1.95 0.14
Others Engulfment and cell motility 2 AA087542 4.80 0.34
Disintegrin, metalloprotease domain 10 AA267983 3.21 0.32
Mad-related protein Smad7 AA068440 2.70 0.28
Homologous to ribosomal RNA processing 4 NM_144886 2.58 0.20
Synaptic vesicle protein 2B AF372834 1.96 0.09
Hypothetical Hypothetical protein AA245492 4.57 0.56
KIAA0719 protein AW545304 3.70 0.93
Hypothetical XM_220393 2.27 0.41
Homo sapiens HSPC137 AW545388 1.92 0.18
B: Down-regulated genes
Energy metabolism Sarcomeric mitochondrial creatine kinase XM_226693 33.58 0.81
Enolase 3L W11965 33.15 0.27
NADH-ubiquinone oxidoreductase W83085 32.59 0.26
Muscle form glycogen phosphorylase W16286 32.34 0.26
ND5 respiratory NADH dehydrogenase S46798 32.08 0.08
ATP synthase subunit c D13123 32.07 0.09
Ion channels, receptors Fibronectin receptor L chain AW544628 33.29 0.53
Sodium/potassium ATPase L AW544502 32.02 0.34
Chloride intracellular channel 4 NM_031818 32.00 0.12
Intracellular chloride channel protein AW539790 31.95 0.20
Protein degradation, folding (chaperones) Proteasome component C9 AA277958 33.60 0.92
Ubiquitin-like protein FUBI AA239437 33.47 0.57
105-kDa heat shock protein AW544862 32.71 0.32
Calreticulin AW545345 32.26 0.35
Chaperonin subunit 5O AA955792 32.00 0.08
Cholesterol synthesis, transport START domain containing 7 W36450 33.61 0.43
Farnesyltransferase L subunit AA259357 32.05 0.09
CEA-related cell adhesion molecule 9 AW545543 31.98 0.12
Others Fibroblast inducible secreted protein W36541 32.68 0.02
Basigin AW544934 32.26 0.43
CD81 antigen NM_013087 32.09 0.35
Hypothetical Hypothetical protein AA403436 34.45 0.51
mKIAA0475 protein AA274981 32.33 0.99
EST W44032 32.33 0.21
EST AA068436 32.17 0.37
S.D., standard deviation.
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Similarly to our previous results [5,8], left ventricular end-
diastolic pressure was signi¢cantly increased in the hyperlipi-
demic group showing a mechanical dysfunction of the heart
(Table 3). Other hemodynamic parameters including coronary
£ow were not changed by hyperlipidemia (Table 3) and no
lactate dehydrogenase release was detected (data not shown)
indicating that hyperlipidemia did not result in restriction of
coronary circulation and development of myocardial ische-
mia. Therefore, gene expression changes observed in this
study can be attributed to a direct e¡ect of chronic hyper-
lipidemia on the myocardium.
We have found that hyperlipidemia signi¢cantly a¡ected
cardiac energy metabolism and the ATP generating machinery
at the level of gene expression, as sarcomeric mitochondrial
creatine kinase, enolase 3L, ND5 respiratory NADH dehydro-
genase, NADH-ubiquinone oxidoreductase, muscle form gly-
cogen phosphorylase, and ATP synthase subunit c were mark-
edly down-regulated (Table 2B) as evidenced by microarray
data and in the case of ATP synthase subunit c by RT-PCR
results as well (Table 4). These data are consistent with recent
observations showing that hypercholesterolemia leads to an
increase in mitochondrial damage in cardiovascular tissues
[28]. Reduced energy metabolism and ATP synthesis may
lead to functional deterioration of hyperlipidemic hearts as
observed in our present and previous studies [5,8].
We have observed down-regulation of genes involved in
cholesterol synthesis and transport in the heart after a high-
cholesterol diet. Steroidogenic acute regulatory protein-related
lipid transfer (START) domains can bind sterol and perform
critical functions in moving the sterol substrate to the mito-
chondrial inner membrane, and stimulate steroidogenesis [29].
The marked down-regulation of a START domain in the
present study suggests that excess exogenous cholesterol in-
hibits intracellular cholesterol transport and steroidogenesis in
the heart. The down-regulation of farnesyltransferase L sub-
unit can be attributed to inhibition of the mevalonate path-
way (the pathway for cholesterol synthesis) due to excess
exogenous cholesterol [30]. We have also observed a moderate
repression of carcinoembryonic antigen-related cell adhesion
molecule 9 (CEACAM9). Members of the CEACAM family
of proteins play a role in the biliary cholesterol crystallization,
promoting low-density protein^lipid complex [31], and serve
as a potent angiogenic factor and a major e¡ector of vascular
endothelial growth factor [32]. These data suggest that dietary
cholesterol reduces cardiac cholesterol synthesis and trans-
port, and con¢rm our previous assumptions that high-choles-
terol diet inhibits the mevalonate pathway thereby reducing
protein prenylation and ubiquinone synthesis [9].
Genes encoding ion transport proteins and ion channels
such as sodium/potassium ATPase L, chloride intracellular
channel 4 (CLIC4), and intracellular chloride channel genes
were also repressed. Decreased activity of sodium/potassium
ATPase increases cardiac contractility, and may therefore be
an adaptive response to attenuate hyperlipidemia-induced loss
of cardiac function [33]. The role of the CLIC family of pro-
teins is poorly understood, and no data are available on the
role of CLIC in the heart; however, cellular volume control,
cellular motility, and apoptosis have been suspected [34^36].
The possible role of CLIC in hyperlipidemia in the heart is an
entirely new observation that needs further study. Another
gene encoding a membrane-bound protein, ¢bronectin recep-
tor L chain gene, was also markedly down-regulated. Integrins
are heterodimeric receptors that couple the extracellular ma-
trix to intracellular signaling pathways and the cytoskeleton.
Integrins have been suggested to play a role in cardiac devel-
opment and several cardiovascular disorders [37,38]. Our
present study is the ¢rst to suggest that down-regulation of
¢bronectin receptor plays a role in the cardiac e¡ects of hy-
perlipidemia.
The most signi¢cantly up-regulated genes were membrane
Table 3
Cardiac functional parameters in control and cholesterol-fed groups
HR CF AF LVDP +dP/dtmax 3dP/dtmax LVEDP
Control 273Q 6 23.0Q 0.5 44.4Q 2.0 18.5Q 0.4 844Q 46 456Q 31 0.51Q 0.05
Chol 271Q 8 21.9Q 0.5 45.1Q 1.3 18.9Q 0.5 935Q 50 478Q 43 0.87Q 0.05*
HR, heart rate (beats/min); CF, coronary £ow (ml/min); AF, aortic £ow (ml/min); LVDP, left ventricular developed pressure (kPa); LVEDP,
left ventricular end-diastolic pressure (kPa); +dP/dtmax (kPa/s); 3dP/dtmax (kPa/s). Values are meansQS.E.M. (n=8 in each group). *P6 0.05,
signi¢cant di¡erence compared to control by Student’s t-test.
Table 4
Con¢rmation of gene expression changes due to high-cholesterol diet-induced hyperlipidemia by real-time PCR in rat hearts
Gene product Accession number Microarray
(average fold)
Real-time PCR
(average fold)
Average Ct
value
Con¢rmed by
real-time PCR
Procollagen, type III, K1 W89883 2.14 4.15 15.24 Yes
Synaptic vesicle protein 2B AF372834 1.96 3.86 14.32 Yes
Tensin U26310 1.97 2.76 16.40 Yes
Heat shock protein, Hsp86 NM_175761 1.95 2.45 16.43 Yes
Protein kinase C inhibitor S NM_022192 1.90 1.74 14.95 Yes
Glycogen synthase kinase 3K NM_032080 1.95 31.60 12.65 No
Metallothionein II H32024 1.97 2.46 16.74 Yes
ATP synthase subunit c D13123 32.07 31.92 10.52 Yes
Chloride intracellular channel 4 NM_031818 32.00 31.74 16.14 Yes
ND5 respiratory NADH dehydrogenase S46798 32.08 32.16 8.56 Yes
Chaperonin subunit 5O AA955792 32.00 32.20 16.98 Yes
CD81 antigen NM_013087 32.09 33.44 14.35 Yes
Ct : threshold cycle.
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proteins, p120 catenin isoform 4B, SH3-containing protein
SH3P4 (endophilin), Clara cell phospholipid binding protein,
and NIPSNAP2 protein coding genes. The exact role of these
proteins in the heart is not known. P120 catenin a¡ects cell^
cell adhesion, as it controls internalization and degradation of
classical cadherins in endothelial cells [39], and it is likely to
have additional roles in the nucleus [40]. It is plausible to
speculate that the expression changes of these membrane pro-
tein genes may be partly the consequence of the possible alter-
ations in membrane composition of the heart due to choles-
terol diet-induced hyperlipidemia.
Several regulatory protein genes were induced after choles-
terol treatment: a protein kinase, a pleiotropic regulator, the
regulatory subunit 9A of the protein phosphatase 1, and a
transcriptional repressor. Among the regulatory protein cod-
ing genes, the protein kinase C inhibitor S gene was slightly
induced, which was con¢rmed by QRT-PCR as well. Induc-
tion of this gene could have a dramatic e¡ect on apoptosis of
cardiomyocytes, as protein kinase C inhibitor S is the critical
downstream target of Bcr-Abl, which mediates the anti-apo-
ptotic e¡ects of Bcr-Abl [41]. Moreover, Wang et al. have
shown that diet-induced hypercholesterolemia in rabbits was
associated with a markedly increased activation of caspase-3
and an increased myocardial Bcl-2/Bax ratio (markers of ap-
optosis) within the ischemic myocardium, showing the in-
creased extent of cardiomyocyte apoptosis [42].
We have previously shown that transcription of hsp70 was
signi¢cantly higher in hearts of rats fed a 2% cholesterol-en-
riched diet compared to normal controls, although the HSP70
protein level was not di¡erent [11]. We have also shown that
hyperlipidemia inhibits expression of cardiac Hsp70 in re-
sponse to heat stress and ischemia [11]. Here, we have de-
tected extensive changes in the expression of stress proteins
due to hyperlipidemia. The induction of heat stress proteins is
well known in response to myocardial, renal, and cerebral
ischemia [43^45], but this is the ¢rst demonstration that
hsp86 and the antioxidants metallothionein II and glutathione
S-transferase can be induced by cholesterol diet. However,
other stress proteins, such as chaperonin subunit 5O, 105-
kDa heat shock protein, calreticulin, and a ubiquitin-like pro-
tein were signi¢cantly down-regulated. The mechanisms
underlying the opposite regulation of these stress proteins
due to high-cholesterol diet would be interesting to clarify,
as still little is known about the function of these proteins
in the heart [46,47].
Opposite changes in transcription of structural protein
genes have been observed in the present study. Genes encod-
ing a ¢brogenic gene (¢broblast-inducible secreted protein)
was down-regulated, while genes for co¢lin/destrin (actin de-
polymerizing factor), calsarcin-1, myozenin-like 2, and procol-
lagen III K1 were induced by high-cholesterol diet. The func-
tion of these proteins in the heart might be some remodeling
process in response to hyperlipidemia. However, very little is
known about the exact role of these genes in the heart.
The activity of numerous genes with diverse function was
also signi¢cantly altered in hearts of rats fed cholesterol-rich
diet as shown in Table 2. For example, we have observed
overexpression of Mad-related protein Smad7. Recent reports
have implicated Smad7 as a crucial regulator of transforming
growth factor L activity in human disease [48] and found that
Smad6 and Smad7 constitute a novel class of MAD-related
proteins, termed vascular MADs, which are induced by £uid
mechanical forces and can modulate gene expression in re-
sponse to both humoral and biomechanical stimulation in
vascular endothelium [49].
Eight clones encoding hypothetical proteins or ESTs having
no homology to known proteins exhibited signi¢cant up- or
down-regulation. The function of these genes and their rela-
tionship to myocardial function and to the e¡ects of choles-
terol need to be elucidated.
In order to con¢rm the di¡erential expression of genes re-
vealed by microarray analysis of rat hearts after cholesterol
diet, several genes were analyzed by RT-PCR. We have se-
lected 12 genes di¡erentially expressed in hearts from choles-
terol-fed animals for real-time RT-PCR analysis (Table 4).
The results for 11 genes were in agreement with the micro-
array data, while in the case of glycogen synthase kinase 3K
gene, the moderate alteration in its expression (a statistically
borderline case) could not be con¢rmed. Genes encoding pro-
collagen type III K1, synaptic vesicle protein 2B, tensin, heat
shock protein Hsp86 and metallothionein II had very signi¢-
cant rises in transcription rate. In all these cases, more pro-
nounced induction could be detected by QRT-PCR than with
the microarray technique. A higher degree of change was also
observed in the repression of CD81 antigen. Gene expression
changes obtained by QRT-PCR for genes encoding ATP syn-
thase subunit c, chloride intracellular channel 4, protein ki-
nase C inhibitor S, ND5 respiratory NADH dehydrogenase,
and chaperonin subunit 5O were repressed and values were
very similar to those obtained in the microarray measure-
ments. Discrepancies in some cases between DNA microarray
and RT-PCR studies have also been reported previously
[22,50] and could be explained by cross-hybridization of ho-
mologous sequences or by other experimental variables intro-
duced by hybridization, labeling, data processing, and nor-
malization variations during microarray analysis.
We conclude that cholesterol-enriched diet-induced hyper-
lipidemia leads to signi¢cant changes in expression of several
genes in rat hearts. As hyperlipidemia does not lead to coro-
nary sclerosis and myocardial ischemia in our rat model, gene
expression changes can be attributed to a direct e¡ect of hy-
perlipidemia on the myocardium. The role of most of the
genes we have found to be regulated by hyperlipidemia is
not exactly known in the heart, therefore, our present ¢ndings
may open new directions in the research of the cardiac e¡ects
of hyperlipidemia.
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